Showing results (61-70 of 198) with videos related to
Sort By:
Pageof 20
Translational Oncology|June 5, 2013
Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator TamoxifenSuraj Konnath George, Veronica Tovar-Sepulveda, Steven S Shen, et al.Acta Biomaterialia|May 4, 2017
Carbon nanotube capsules enhance the in vivo efficacy of cisplatinAdem Guven, Gabriel J Villares, Susan G Hilsenbeck, et al.Development (Cambridge, England)|February 9, 2007
Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasiaRicardo C Moraes, Xiaomei Zhang, Nikesha Harrington, et al.Cancer Prevention Research (Philadelphia, Pa.)|October 20, 2021
Targeting the Pro-survival Protein BCL-2 to Prevent Breast CancerAdelaide Young, Wen Bu, Weiyu Jiang, et al.Breast Cancer Research : BCR|August 26, 2009
Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progressionBrandy M Heckman-Stoddard, Tracy Vargo-Gogola, Peter R McHenry, et al.Breast Cancer Research and Treatment|October 26, 2005
Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapiesMichelle D Martin, Susan G Hilsenbeck, Syed K Mohsin, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 18, 2008
Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasmsWilliam E Fisher, Sally E Hodges, Vivek Yagnik, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2011
Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patientsThushangi N Pathiraja, Priya B Shetty, Jaroslav Jelinek, et al.The Journal of Experimental Medicine|April 8, 2018
Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP miceAngie C A Chiang, Stephanie W Fowler, Ricky R Savjani, et al.Breast Cancer Research and Treatment|October 1, 2013
Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancerKyle R Covington, Lauren Brusco, Ines Barone, et al.Pageof 20